Access cutting-edge pulmonary arterial hypertension treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.
Access pulmonary arterial hypertension specialists in Aurora at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pulmonary arterial hypertension treatment provided free
Researchers are looking for other ways to treat pulmonary arterial hypertension (PAH). Sotatercept is a study medicine that is designed to treat PAH. A past study, MK-7962-024 (LIGHTRAY) (NCT06664801), learned about the safety and effects of sotatercept in people with PAH. One of the goals of that study was to learn about sotatercept when given at a dose (amount) based on the weight range a person is in (weight-banded doses) compared to when given based on a person's exact weight. This is an e
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this pulmonary arterial hypertension clinical trial in Aurora, CO
If you're searching for pulmonary arterial hypertension treatment options in Aurora, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary arterial hypertension specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.